JPRN-UMIN000010667已完成3 期
Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer (JCOG1113, FUGA-BT) - Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine pluscisplatin combination therapy in advanced biliary tract cancer (JCOG1113, FUGA-BT)
Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 350 人开始时间: 2013年5月8日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Synchronous or metachronous (within 5 years) malignancies except carcinoma in situ or intramucosal tumor curatively treated with local therapy 2) Active infection requiring systemic therapy 3) Pregnant or lactating women or women of childbearing potential, Male expecting partner's pregnancy 4) Psychiatric disease 5) Patients requiring systemic steroids medication 6) Interstitial pneumonia, pulmonary fibrosis 7) Serious co-existing illness 8) Unstable angina pectoris within 3 weeks, or with a history of myocardial infarction within 6 months 9) Patients requiring flucytosine, phenytoin or warfarin 10) Impossible to use both iodine and gadolinium due to being allergic to contrast agent
研究者
相似试验
已完成
不适用
A phase 3 study of gemcitabine and S-1 compared with gemcitabine monotherapy in patients with unresectable advanced pancreatic cancer.pancreatic cancerJPRN-UMIN000002244Chiba Cancer Center100
进行中（未招募）
1 期
Randomized phase III study of gemcitabine and cisplatin (GC) versus high dose intensity methotrexate, vinblastine, doxorubicin and cisplatin (HD-MVAC) in the perioperative setting for patients with locally advanced transitional cell cancer of the bladder.locally advanced transitional cell cancer of the bladderMedDRA version: 15.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-000563-25-FRCHU-Hôpitaux de Rouen500
已完成
2 期
Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinomaPancreatic ductal adenocarcinomaJPRN-UMIN000021484Clinical study group of Osaka university, Hepato-Biliary- Pancreatic group100
已完成
2 期
Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine in advanced biliary tract cancer (GS-COMBI).Advanced biliary tract cancerJPRN-UMIN000001703Japanese Endoscopist & IVRists group for Biliary Tract Cancer (JEIBIC)62
招募中
2 期
PDAC-GS/GA-rP2JPRN-jRCTs051180122Kobayashi Syogo100